Sentences with phrase «at therapeutic research»
We are happy to announce that our friends at Therapeutic Research Center have offered subscribers to Pharmacy Technician Headquarters incredible savings on their two feature products for pharmacy technicians, Pharmacy Technician's Letter ™ AND Pharmacy Technician University ™ (SEE BELOW FOR DETAILS).
http://www.pharmacytechnicianhq.com/ Not exact matches
She believes her research will give great value to a product that up to this time has been simply a waste product, the coconut residue, but which in fact has great therapeutic value at the fraction of the cost of expensive western medicines.
Dr. Janaki Gooneratne, the head of Food Technology at the Industrial Technology Institute in Sri Lanka, conducted the research while analyzing the therapeutic value of coconut residue products in relation to heart disease.
New York City Councilman Antonio Olivieri, who died of cancer in 1980 at age 39, had lobbied for state medical marijuana use for therapeutic research.
A research group headed by Gustavo Turecki, professor of psychiatry at McGill University in Montreal, Canada, recently used the platform to show that miRNAs can be used as prognostic markers for therapeutic responses to an antidepressant medication in patients with major depressive disorder (3).
Of approximately 300 staff at the Center for Therapeutic Research, only nine postdocs and students are conducting basic research; the rest work in drug discovery and deveResearch, only nine postdocs and students are conducting basic research; the rest work in drug discovery and deveresearch; the rest work in drug discovery and development.
Gervais was so impressed by the apoptosis research that he later approached Nicholson about doing a postdoc in his lab, which is based at the Merck Frosst Center for Therapeutic Rresearch that he later approached Nicholson about doing a postdoc in his lab, which is based at the Merck Frosst Center for Therapeutic ResearchResearch.
Richard Hargreaves, executive director of imaging at Merck Research Laboratories, says, «Nuclear imaging using radiotracers gives the opportunity to put your arms around proof - of - concept very early in a drug discovery and development program by focusing the selection of doses to study on those proven to deliver enough drug to the target therapeutic sites.»
At a handful of sites across the country, after a four - decade hiatus, psychedelic research is undergoing a quiet renaissance, thanks to scientists like Charles Grob who are revisiting the powerful mind - altering drugs of the 1960s in hopes of making them part of our therapeutic arsenal.
«Targeting the drivers of aging and senescent cells may be a novel therapeutic strategy to reduce hepatic steatosis and liver fibrosis in ALD patients,» commented co-author Gianfranco Alpini, PhD, Distinguished Professor in the Department of Medical Physiology at Texas A&M College of Medicine, Senior Research Scientist at Central Texas Veterans Health Care System, and Director of the BSW DDRC.
Until now, EGFR inhibitors have only been effective at treating the 10 to 15 percent of non-small cell lung cancers that have a variant of EGFR, but the two - drug combo could potentially work for all non-small cell lung cancers, explained Dr. John Minna, Director of the Hamon Center for Therapeutic Oncology Research and Professor of Internal Medicine and Pharmacology.
«Using approved therapies for one condition to treat another, or drug repurposing, offers new avenues to speed Parkinson's therapeutic development,» said Dr Brian Fiske, senior vice president of research programs at MJFF.
«We are excited by the work of Dr. Pourdehnad and colleagues and believe these results are an important advance in understanding the role of myc pathway dysregulation in multiple myeloma, and ultimately allow for the development of therapeutic strategies to address it,» said Jeffrey Wolf, MD, a UCSF blood disorder specialist and director of the Stephen and Nancy Grand Multiple Myeloma Translational Initiative at UCSF, a sponsor of the research.
University of Calgary researchers including Luchman, Weiss and Dr. Greg Cairncross — director of SACRI, and leader of the Terry Fox Research Institute (TFRI) «Therapeutic Targeting of Glioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with gliobResearch Institute (TFRI) «Therapeutic Targeting of Glioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with gliobresearch program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblastoma.
After a successful postdoc at the Ontario Cancer Institute, where he developed a proprietary platform for the discovery of novel cancer therapeutic agents, Bray was asked to join the former Amgen Research Institute in Toronto (now called the Advanced Medical Discovery Institute and no longer part of the parent company) as the head of their quantitative biology group and act as liaison to Amgen Inc. in California.
Katerina Akassoglou, PhD, and her research team at the Gladstone Institutes uncovered a promising new therapeutic strategy.
Now, a research team based at Nagoya University used plasma to activate Ringer's solution, a salt solution with existing therapeutic functions, and showed that its lactate component had anti-tumor effects.
The research is part of the Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) trials, which enrolled over 600 children over six years at more than 40 clinical centers throughout the U.S., Canada and United Kingdom.
The paper, by S.S. Karuppagounder at Burke Medical Research Institute in White Plains, N.Y., and colleagues was titled, «Therapeutic targeting of oxygen - sensing prolyl hydroxylases abrogates ATF4 - dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.»
«Our research could lead to therapeutic opportunities,» said Yang Xia, M.D., Ph.D., the study's senior author and a professor in the Department of Biochemistry and Molecular Biology at the UTHealth Medical School.
«Physicians do use the database, but it's not yet common for them to use it for every prescription because it's still lacking a lot of information on pharmaceuticals,» said Lööf, chairman of the Drug Therapeutic Committee at the Centre for Clinical Research in Västerås, which works with local physicians to provide drug therapy strategies.
Rod Kellems, Ph.D., study co-author and chairman of the Department of Biochemistry and Molecular Biology at the UTHealth Medical School, added, «This research provides insight into how red blood cells work, revealing that SphK1 - mediated elevation of S1P contributes to sickling and promotes disease progression and highlights potential therapeutic opportunities for sickle cell disease.»
The one developed by Zhang and his team, including Ph.D. student Inga Haedicke, U of T Assistant Professor Hai - Ling Margaret Cheng and two research groups (Dr. Timothy Scholl and Dr. Paula Foster) from Western University, can improve monitoring at the cellular level, which is a crucial element in measuring the effectiveness of stem and therapeutic cell treatments.
turned into 10 years of systematic research to identify the enzyme PLK4 as a promising therapeutic target and develop a small molecule inhibitor to block it,» says Dr. Mak, Director of The Campbell Family Institute for Breast Cancer Research at the Princess Margaret Cancer Centre, University Health research to identify the enzyme PLK4 as a promising therapeutic target and develop a small molecule inhibitor to block it,» says Dr. Mak, Director of The Campbell Family Institute for Breast Cancer Research at the Princess Margaret Cancer Centre, University Health Research at the Princess Margaret Cancer Centre, University Health Network.
This clinical trial is the culmination of long - standing research led by Professor John Greenwood at the UCL Institute of Ophthalmology showing the potential therapeutic benefits of using statins to treat autoimmune diseases such as multiple sclerosis and uveitis.
«It's the proof of concept that through therapeutic vaccination we can really re-educate our T cells to control the virus,» says Beatriz Mothe, a clinician at IrsiCaixa AIDS Research Institute in Barcelona, Spain, who presented the results here at the Conference on Retroviruses and Opportunistic Infections.
Expanding the Therapeutic Window for Treatment As PI at MSM, Ford takes what he learned during his training and applies it to stroke — caused by blockage or rupturing of arterial blood flow leading to or in the brain — and atherosclerosis — hardening of arteries over time due to fat - deposit build - up on their inner lining — research.
The authors hope their hypothesis will promote research to investigate the mechanisms that underlie this hypertension, as well as preventative and therapeutic strategies for this potentially at - risk population.
Blackburn, a cell biologist at the University of California at San Francisco, charges she was released for speaking out in favor of therapeutic cloning and against federal funding restrictions on stem cell research.
«It's probably premature to run large trials without evidence that they have a therapeutic effect that [we] understand,» cautions Arnold Kriegstein, director of the Broad Center of Regenerative Medicine and Stem Cell Research at the University of California, San Francisco.
The research — published January 3, 2017 in the online journal eLife — was led by Joshua Galanter, MD, MAS, formerly an assistant professor of medicine, of bioengineering and therapeutic sciences, and of epidemiology and biostatistics at UCSF, who is now a scientist at Genentech.
Dr Martin Reijns, Senior Research Fellow at the MRC Human Genetics Unit, said: «We hope that this research will inform future studies into the development of improved therapeutic approachesResearch Fellow at the MRC Human Genetics Unit, said: «We hope that this research will inform future studies into the development of improved therapeutic approachesresearch will inform future studies into the development of improved therapeutic approaches.»
«The dBET1 and the dFKBP12 compounds are presently in a late stage of lead optimization for therapeutic development in both cancer and non-malignant diseases,» says Prem Das, PhD, chief research business development officer at Dana - Farber.
«There's a huge body of research showing that alcohol hand rinses are actually much better at getting rid of bacteria than soap,» says Elaine Larson, a professor of pharmaceutical and therapeutic research at the Columbia University School of Nursing.
A team of researchers at Mayo Clinic and The Scripps Research Institute in Florida have developed a new therapeutic strategy to combat the most common genetic risk factor for the neurodegenerative disorders amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and frontotemporal dementia (FTD).
«This mechanism may offer the potential to develop an entirely new therapeutic approach,» says C. Ronald Kahn, M.D., Joslin's chief academic officer, Mary K. Iacocca Professor of Medicine at Harvard Medical School and senior author of a paper on the research published in the journal Nature.
«In recent years, several therapeutic medicines have been developed that spur a person's own immune system to fight cancer,» said Raul Torres, PhD, professor of immunology at National Jewish Health, and senior author on the paper, published in the October issue of Cancer Immunology Research.
«In cases where you are trying to make therapeutic decisions, you want to have some numbers that you can fall back on,» says Vincent Liu, a graduate student in Cima's lab at MIT's Koch Institute for Integrative Cancer Research and lead author of the paper.
She holds a Tier 2 Canada Research Chair in Aging & Immunity, and investigates how changes in the immune system of older adults and vulnerable populations predispose them to pneumonia infection.The aim of Dr. Bowdish's research at McMaster University is to develop novel preventative and therapeutic strategies that reduce the burden of pnResearch Chair in Aging & Immunity, and investigates how changes in the immune system of older adults and vulnerable populations predispose them to pneumonia infection.The aim of Dr. Bowdish's research at McMaster University is to develop novel preventative and therapeutic strategies that reduce the burden of pnresearch at McMaster University is to develop novel preventative and therapeutic strategies that reduce the burden of pneumonia.
The findings, being presented as part of a poster presentation at the Annual Meeting of the American Association for Cancer Research (AACR) being held in Philadelphia this week, could have therapeutic implications specific to this rare form of the disease, say the authors.
These students and faculty work on a broad spectrum of research problems that share at least one of the four goals of Bio-X: to image and simulate life from molecules to mind, to restore the health of cells and tissues, to decode the genetics of health and disease, and to design therapeutic devices and molecular machines.
The conference aims at bringing together international experts from different fields of cancer research to present and discuss new therapeutic approaches regarding different tumor entities as well as new findings in the field of tumor biology seeking to incorporate innovative platforms into cancer research.
Before he joined Moderna in 2013, Dr. Frederick was a Translational Research group leader at Aveo Oncology, focused on the generation of biomarkers for therapeutic response prediction, as well as avenues to modulate the tumor microenvironment for therapeutic benefit.
The meeting featured a keynote address from Bruce R. Conway, PhD, Director of the Robertson Therapeutic Development Fund at The Rockefeller University, as well as a panel discussion on best practices for translational science featuring Dr. Conway, Michael L. Batten, MD, MBA, of the JDRF T1D Fund, Andres Hurtado - Lorenzo, PhD, Director of Translational Research at the Crohn's & Colitis Foundation, Elizabeth Schwarzbach, PhD, Vice President of Business Development at NYSCF, and Caren A. Heller, MD, MBA, of the Crohn's & Colitis Foundation.
To help Gladstone discoveries successfully cross through the valley of death, the Hellman Family Foundation Alzheimer's Research Program subsidizes the myriad of early - stage, de-risking tests necessary to make a drug candidate more attractive to pharmaceutical - industry partners, such as tests that reveal at what concentrations a drug stops being therapeutic and instead becomes toxic.
However, patients are now able to participate in two research projects aimed at understanding this disease in order to make discoveries which may lead to better therapeutic options.
Previously Dr. Martini worked at Shire plc in Lexington, Mass., as Senior Director of Discovery Biology and Translational Research, Mass., focusing on fibrotic diseases of muscle, kidney, skin, lung, bone marrow and metabolic liver diseases, with particular emphasis on different therapeutic modalities for pathway modulation.
In addition, Dr. Gudkov has presented these new data today at the Research Workshop of the Israel Science Foundation 2016 called Cellular Senescence: From Molecular Mechanisms to Therapeutic Opportunities, which attracted top internationally recognized experts in senescence and aging.
Two recent developments involving the California Institute for Regenerative Medicine (CIRM) again serve to underscore the reality that adult and other non-embryonic avenues of stem cell research are advancing at a far more dramatic pace toward providing actual therapeutic benefits for patients than is human embryonic stem cell research (hESCR).
The study conducted in the laboratory of Don Cleveland, Ph.D., UCSD Professor of Medicine, Neurosciences and Cellular and Molecular Medicine and member of the Ludwig Institute for Cancer Research, shows that therapeutic molecules known as antisense oligonucleotides can be delivered to the brain and spinal cord through the cerebrospinal fluid (CSF) at doses shown to slow the progression of ALS in rats.